Official NLSDays 2021 Digital Opening
20 April 2021
Official NLSDays 2021 Digital Opening
We are 27 million-strong, with shared values of openness, trust, sustainability, and equality, making the Nordics the perfect setting for partnerships & investments. In this session, we celebrate our Nordic Region with a Keynote by Cytiva CEO, Emmanuel Ligner, and a showcase of our 2021 Flagships, selected for their personal contribution to Nordic values & success. It is by coming together as a unified region that we are a greater force to be reckoned with globally – and we can see why when we take a look at what we each contribute nationally:
- Finland has mastered the art of building trust into research, which has enabled the digitization of national health data registries & biobanks and the launch of FinnGen, a world-renowned personalized medicine public-private collaboration.
- Iceland has discovered that sustainability and the utilization of natural resources are not only possible in life sciences, but also beneficial in every way – for the patient, the environment, and the economy.
- Denmark is our European leader in clinical trials per capita, showing us that their solution-oriented and synergetic approach across an array of well-developed R&D infrastructures is a model from which can all learn.
- Norway has blossomed into a land in which technology meets medicine. There, we find a hotbed of both developers and early adopters, all of whom understand that Precision Medicine & technology are our keys to success.
- Last, but not least, Sweden, where innovation is in the DNA. Sweden’s is a vibrant ecosystem comprising hundreds of SMEs – biotechs, medtechs, digital health – as well as global players. Combined, you have a healthy soil in which all can grow.
Moderator(s): Ms. Helena Strigård - Director General, SwedenBIO
“It is great to be a part of NLSDays to tell the story of Kerecis and network with other companies in the biotech space. I am now more convinced than ever that the groundbreaking developments that are taking place in the Nordic region truly will make a great impact on our lives,”
Residual fish skin has formed the basis of Iceland’s fastest growing company, Kerecis. Skin from cold water fish is naturally rich in Omega-3, which accelerates wound healing and is also ideal for human tissue as there is no risk of infection between such cold-water fish and humans. The company’s vision is to become the world leader in tissue regeneration by sustainably harnessing nature’s own remedies. www.kerecis.com
“NLSDays 2021 is a great opportunity to learn about the strong innovation emerging from the Nordics, as well as to share experiences and best practices,”
EXACT-Tx is a clinical stage Anglo-Norwegian biotech company developing a technology platform for targeted therapeutic enhancement – Acoustic Cluster Therapy (ACT®). ACT® sonoporation is a unique approach to ultrasound-mediated, targeted drug enhancement – with the potential to significantly amplify the clinical utility of a wide range of therapeutic agents across a multitude of indications including within oncology (chemotherapy, immunotherapy), infectious diseases, and neurological conditions. www.exact-tx.com
“It’s a great pleasure to speak and network with other entrepreneurs, business leaders, and innovators during the NLSDays 2021. The life science industry is going through a major revolution and what brought us here won’t bring us to the future we want to achieve. In the name of being able to create the future of medicine together, we need to learn to work together, to establish fruitful collaborations – and that can only be done if we learn to share our stories, ideas, and get to work,”
In 2016, Cellink commercialized the world’s first universal bioink, the first of many milestones in becoming the world’s leading bioprinting company. In 2020, after 3 successful acquisitions and multiple successful products launched, a bigger idea developed. With the combination of cutting-edge engineering, big data and AI initiatives, and biology, the first bio-convergence company has now emerged. www.cellink.com
“Unique Danish funding opportunities for promising and emerging innovations were essential to our early establishment and growth. Likewise, NLSDays is a unique platform that brings together the entire Nordic life science community, not only giving us the possibility of connecting with a relevant VC and Pharma community, but also helping us to establish new partnerships across the Nordic region,”
PanCryos, a spinout from the Novo Nordisk Foundation Center for Stem Cell Biology at the University of Copenhagen, is devoted to improve the quality of life for the millions of people suffering from type 1 diabetes. The company is developing a best-in-class stem cell derived allogeneic cell therapy (PanINSULA™) that will provide the same glucose control as the pancreatic islet: sensing changes in blood glucose and producing Insulin Naturally. pancryos.com
“As global healthcare systems and organizations are adopting digital technologies such as AI at an ever increasing pace, it is crucial for us as the providers of these transformative solutions to collaborate with each other as well as with the medical professionals adopting these technologies. NLSDays provides that platform for us to share and communicate our vision by bringing together industry leaders across a wide array of fields,”
Aiforia’s mission is to provide the most powerful tools for AI-assisted analysis to enhance the translation of medical images into data and discoveries in all realms of healthcare. From scientific research to clinical diagnostics, Aiforia aims to outfit healthcare professionals with the digital solutions they need for the shifting landscape of medicine. www.aiforia.com